Director gifts 1,000 Addus HomeCare (ADUS) shares to the Weaver Charitable Fund.
Addus HomeCare Corp (ADUS) director Susan T. Weaver made a bona fide gift of 1,000 common shares to the Weaver Charitable Fund on November 12, 2026. This transaction was for no consideration, and her direct holdings after the gift totaled 12,744 shares. The filing notes that no Rule 10b5-1 plan was reported for this transaction.
Learn Why The Bull Case For Addus HomeCare Stock Could Change Following Earnings Beat
Addus HomeCare reported strong third-quarter 2026 earnings, surpassing prior year figures with US$28.59 million in net income and diluted EPS of US$1.54. This profitability, combined with upcoming investor presentations, reinforces the company's home-based care strategy. The earnings beat and active communication could influence investor sentiment, potentially leading to a re-evaluation of the stock's valuation, which currently suggests a 7% potential upside.
Form 144 ADDUS HOMECARE CORPORATION For: 11 November By Investing.com
This article announces the filing of Form 144 for Addus HomeCare Corporation on November 11. It's a brief financial news item from Investing.com, indicating a regulatory filing related to the company. The article includes the stock symbol ADUS and notes a 3.16% change.
Addus HomeCare EVP Cliff Donald Blessing Sells 2,000 Shares at $124.18 Average Price
Cliff Donald Blessing, EVP and Chief Development Officer of Addus HomeCare Corp (NASDAQ:ADUS), sold 2,000 shares of the company's common stock on November 6, 2026, at a weighted average price of $124.18 per share. This transaction, revealed in a Form 4 filing, leaves Blessing with 10,183 shares of common stock directly owned. The sale involved multiple transactions ranging from $124.02 to $124.34.
Addus HomeCare (ADUS) Posted Higher Earnings, Is The Stock Still Cheap?
Addus HomeCare (ADUS) reported strong third-quarter results with net income of US$28.59 million and diluted EPS of US$1.54, both up from the prior year. The stock responded positively, with a 3.16% 1-day gain and an overall year-to-date gain of 18.49%, now trading at US$126.29. Despite the recent gains, Simply Wall St's analyst consensus suggests the stock is still modestly undervalued with a fair value of $133.69, driven by its scale in personal care, technology, and strategic acquisitions like AccentCare's personal care division.
An EVP sells 7,141 shares and exercises 5,000 options at Addus HomeCare (ADUS).
Michael D. Wattenbarger, EVP and Chief Information Officer of Addus HomeCare (ADUS), exercised 5,000 employee stock options at $87.80 per share and subsequently sold 7,141 common shares in multiple transactions on November 6, 2026. The sales were conducted at weighted-average prices ranging from $124.38 to $125.78 per share, with total approximate gross sale proceeds of $890,000 and an exercise cost of $439,000. Following these transactions, Wattenbarger's direct holdings include 7,303 common shares.
Officer Darby Anderson proposes selling 6,740 Addus HomeCare (ADUS) shares.
Darby Anderson, an officer at Addus HomeCare Corp. (ADUS), has proposed selling 6,740 common shares with an approximate aggregate market value of $827,084.27. The shares were acquired on November 10, 2026, through a stock option exercise, with cash listed as the payment method. The proposed sale date is also November 10, 2026.
CFO sells Addus HomeCare (ADUS) shares at average prices of $124.37 and $125.10.
Addus HomeCare Corp's Executive Vice President and CFO, Brian Poff, reported two direct sales of common stock on November 6, 2026. He sold 3,455 shares at a weighted average price of $124.37 per share and an additional 3,189 shares at a weighted average of $125.10 per share. These transactions resulted in Poff selling 10.4% of his position, totaling 6,644 shares valued at approximately $829,000.
A live webcast of Addus HomeCare’s conference presentation starts Nov. 17; a replay stays online for a month.
Addus HomeCare Corporation (Nasdaq: ADUS) will participate in the 2026 Stephens Annual Investment Conference from November 17-19 in Nashville, Tennessee. The company's Chairman and CEO, Dirk Allison, and EVP and CFO, Brian Poff, will attend. A live webcast of their presentation will be available on the company's investor relations website starting November 17, 2026, at 12:00 p.m. Eastern Time, with a replay accessible for one month.
An officer proposes selling 98,958 Addus HomeCare (ADUS) shares acquired through options.
Dirk Allison, an officer and director at Addus HomeCare Corp (ADUS), has proposed selling 98,958 common shares, valued at approximately $12.2 million, with an anticipated sale date of November 9, 2026. These shares were acquired through a stock option exercise, paid for in cash on the same date. The proposed sale is being handled by Morgan Stanley Smith Barney LLC.
An officer proposes selling 7,141 Addus HomeCare (ADUS) shares on November 6, 2026.
Michael Douglas Wattenbarger, an officer at Addus HomeCare Corp (ADUS), has filed a notice of a proposed sale of 7,141 common shares with an aggregate market value of $890,254.94. The proposed sale date is November 6, 2026, and the acquisition history includes restricted stock and shares from a stock option exercise. This Form 144 filing indicates a planned transaction of insider-held shares.
Form 144 ADDUS HOMECARE CORPORATION For: 6 November By Investing.com
This article from Investing.com announces the filing of Form 144 for ADDUS HOMECARE CORPORATION, dated November 6. Form 144 is a notice of the intent to sell restricted securities, typically filed by company affiliates. The article provides minimal detail beyond the announcement and company name.
Form 144 ADDUS HOMECARE CORPORATION For: 6 November By Investing.com
This article announces the filing of Form 144 for ADDUS HOMECARE CORPORATION on November 6. It appears to be a brief news alert from Investing.com, providing basic information about the filing and the company's stock performance (-1.97%).
Addus HomeCare Officer Michael D. Wattenbarger Announces Intent to Sell 7,141 Shares Worth $890K
Michael D. Wattenbarger, an officer at Addus HomeCare Corporation, has filed a Form 144 notice to sell 7,141 shares of common stock, valued at $890,254.94. The sale is scheduled for November 6, 2026, through Morgan Stanley Smith Barney LLC. These shares originate from restricted stock grants and a recent stock option exercise, with no prior sales reported in the last three months.
An officer’s proposed Addus HomeCare (ADUS) sale includes 12,500 shares listed under a stock-option exercise.
Addus HomeCare Corp (ADUS) officer David Tucker has proposed selling 14,850 common shares with an aggregate market value of $1,852,566.40, through Morgan Stanley Smith Barney LLC on November 6, 2026. The proposed sale includes restricted-stock lots and 12,500 shares from a cash stock-option exercise. Following the sale, Tucker's reported holdings will be 18,633,316 shares.
Officer Monica Sue Raines proposes selling 2,062 Addus HomeCare (ADUS) shares.
Monica Sue Raines, an officer at Addus HomeCare Corp (ADUS), has proposed selling 2,062 common shares with an aggregate market value of approximately $257,216.77. The shares were acquired through a cash-paid stock option exercise on November 6, 2026, the same day as the approximate sale date. Morgan Stanley Smith Barney LLC is named as the broker for this transaction.
Officer Brian Poff proposes selling 6,644 Addus HomeCare (ADUS) shares.
Addus HomeCare officer Brian Poff has proposed selling 6,644 common shares, valued at approximately $828,625.73, through Morgan Stanley Smith Barney LLC. The sale date is approximated for November 6, 2026, and the shares are restricted stock acquired from the issuer on three separate dates in February 2026. This notice, filed as a Form 144, also indicates 18,633,316 shares were outstanding.
Addus Targets Q1 2027 AccentCare Close, 13% Adjusted EBITDA Margin
Addus HomeCare Corporation aims to finalize its acquisition of AccentCare by the first quarter of 2027, a $275 million deal expected to add $280 million in annualized revenue, pending regulatory approvals. The company also projects its full-year adjusted EBITDA margin to be around 13%. This outlook follows a strong third quarter with $387.7 million in revenue, a 7% increase from the previous year.
Caregiver Desires For 40-Hour Weeks Shape Addus’ Personal Care Census Strategy
Addus HomeCare Corporation reported a decline in personal care census in Q3, attributing it to caregivers' increasing desire for 40-hour work weeks. The company is addressing this by rolling out a caregiver app to help staff more authorized hours and by being more selective about accepting higher-hour cases. Addus also plans to grow its home health arm and expects to close its acquisition of AccentCare’s personal care assets in Q1 2027, which will significantly increase its revenue base and expand its presence into new states.
Earnings call transcript: Addus HomeCare tops Q3 2026 EPS forecast
Addus HomeCare reported strong third-quarter 2026 adjusted earnings of $1.83 per share, surpassing analyst estimates, though revenue of $387.7 million slightly missed forecasts. The company highlighted robust growth in personal care, hospice, and home health segments, driven by solid operational execution and strategic acquisitions. Addus also announced an anticipated Q1 2027 closure for its AccentCare personal care acquisition, aiming to expand market density and enhance its private pay business.
Addus HomeCare Q3 2026 Earnings Call Transcript
Addus HomeCare reported a 7% revenue increase and 17.3% adjusted EPS growth for Q3 2026, reaching $387.7 million and $1.83, respectively. The company is progressing with the AccentCare personal care acquisition, which will add $280 million in annualized revenue and enhance market density. Strategic initiatives include leveraging technology for improved service delivery, pursuing clinical acquisitions, and aiming for flat to slightly positive census growth in Q4, supported by state rate increases and a strong balance sheet for M&A.
ADUS Q3 2026 deep dive: steady organic growth and AccentCare acquisition set stage for expansion
Addus HomeCare (ADUS) met Wall Street's Q3 2026 revenue expectations, with sales up 7% year-on-year to $387.7 million and non-GAAP profit slightly exceeding estimates. The company's performance was driven by organic growth in personal care, hiring momentum, and operational improvements, further bolstered by the integration of recent acquisitions and the impending AccentCare personal care acquisition. Future growth is expected through continued strategic acquisitions, favorable Medicaid rate developments, and ongoing technology investments.
Addus HomeCare (ADUS) Surpasses Q3 Earnings Estimates
Addus HomeCare (ADUS) reported Q3 earnings of $1.83 per share, exceeding the Zacks Consensus Estimate of $1.78 and the previous year's $1.56 per share. Despite missing revenue estimates slightly, the company has consistently surpassed EPS estimates over the last four quarters. The stock currently holds a Zacks Rank #3 (Hold), indicating it is expected to perform in line with the market.
Addus HomeCare: Q3 Earnings Snapshot
Addus HomeCare Corp. (ADUS) reported third-quarter earnings that surpassed Wall Street expectations, with net income of $28.6 million and adjusted earnings of $1.83 per share. However, the company's revenue of $387.7 million missed Street forecasts. Addus HomeCare shares have seen an 18% increase year-to-date and a more than 6% increase over the last 12 months.
Addus HomeCare’s (NASDAQ:ADUS) Q3 2026 earnings results: revenue in line with expectations
Addus HomeCare (NASDAQ:ADUS) reported Q3 2026 earnings, meeting Wall Street's revenue expectations with a 7% year-on-year increase to $387.7 million. The company's non-GAAP profit of $1.83 per share beat analyst estimates by 2.1%. Addus HomeCare demonstrated solid long-term revenue and EPS growth, with analysts projecting continued, albeit decelerated, growth for the next 12 months.
Addus HomeCare Corporation (ADUS) Stock forecasts
Argus has raised its target price for Addus HomeCare Corporation (ADUS) stock to $133.00, up from its current price of $126.03. The company specializes in providing in-home personal care services. This report, published on October 28, 2026, also includes a summary of the company's business activities.
Addus HomeCare stock hits 52-week high at $124.61
Addus HomeCare Corporation (ADUS) stock reached a 52-week high of $124.61, reflecting investor confidence despite a slight one-year decline and mixed analyst ratings. The company reported strong Q2 earnings and revenue, exceeding expectations, and is considered undervalued by InvestingPro analysis. While Raymond James initiated an "Outperform" rating, BofA Securities downgraded the stock to "Neutral" due to concerns about slowing organic growth.
Addus HomeCare stock hits 52-week high at $124.61 By Investing.com
Addus HomeCare Corporation (ADUS) stock reached a new 52-week high of $124.61, reflecting strong investor confidence and a 26% return over the past six months. Despite a slight one-year decline and mixed analyst ratings, the company reported higher-than-expected Q2 earnings and revenue, with InvestingPro suggesting the stock remains undervalued.
Addus HomeCare Must Prove Its Personal Care Census Turn Is Durable As Shares Press Highs
Addus HomeCare needs to demonstrate that the recent turnaround in its personal care business census is sustainable when it reports third-quarter results on November 3. The company's stock has already priced in a positive trend, but further sequential census gains and stable margins are crucial for validating this outlook, especially given the lack of rate increases in key markets. Investors will also be watching for updates on capital deployment and home health segment improvements.
Addus HomeCare And Two Other Stocks Trading Below Estimated Intrinsic Value
This article identifies Addus HomeCare (ADUS), Daktronics (DAKT), and Hanmi Financial (HAFC) as undervalued stocks based on discounted cash flow analysis. Each company is discussed with an overview, operational details, estimated discount to fair value, and growth prospects, with their respective stock prices trading significantly below their estimated intrinsic values. The U.S. market is noted as having remained flat recently but is up 8.1% over the past year, with projected annual earnings growth of 17%.
Addus HomeCare Corporation Estimates – NASDAQ:ADUS
This page provides financial actuals and analyst estimates for Addus HomeCare Corporation (NASDAQ: ADUS). Users can explore reported financial data and compare actual results with average, high, and low estimates across various financial statements and valuation metrics. The platform also allows visualization of trends over time for income statements, balance sheets, and cash flow on both annual and quarterly bases.
Eleven analysts set a USD 129.33 target for Addus HomeCare stock
Eleven analysts have set an average price target of USD 129.33 for Addus HomeCare (ADUS) stock. This target is based on a mix of buy, strong buy, hold, and sell ratings, and stands about 10.09% above its recent Nasdaq trading price of USD 117.48. The company recently reported an 8.00% increase in second-quarter revenue to USD 377.41 million, and is scheduled to release its September 2026 results on November 2, 2026.
Eleven analysts set USD 129.33 target for Addus HomeCare stock
Eleven research firms have set an average 12-month target of USD 129.33 for Addus HomeCare stock (ADUS), which is 11.51 percent above its recent Nasdaq closing price of USD 115.98. The consensus is a "Moderate Buy," with varied ratings from buy to sell. Investors are looking forward to the third-quarter results release on November 3, 2026, to assess if revenue growth can be maintained and earnings remain above expectations.
Addus HomeCare Corporation (ADUS) Stock forecasts
Argus has raised its target price for Addus HomeCare Corporation (ADUS) to $126.00. The company, which provides in-home personal care services, currently trades at $115.98. The report was issued on October 14, 2026.
Addus HomeCare stock has a USD 129.33 consensus target
Addus HomeCare (ADUS) has a consensus analyst target of USD 129.33, indicating potential upside from its current Nasdaq price of USD 117.16. The company reported an 8.00% increase in second-quarter revenue to USD 377.41 million and is set to release third-quarter results on November 3, 2026. The stock is currently trading below its 52-week high with a trailing P/E ratio of 20.55.
Addus HomeCare Corporation (ADUS) Stock Forecasts
Argus has raised its target price for Addus HomeCare Corporation (ADUS) to $126.00. The company, which provides in-home personal care services, is currently trading at $116.49. This upgrade comes as part of a quantitative report from October 14, 2026.
Addus HomeCare Q2 Results: Net profit rises 25% YoY
Addus HomeCare reported a 25.2% year-over-year increase in net income to $27.6 million for Q2 2026, with revenue growing 8.0% to $377.4 million, driven by strong performance in personal care and hospice segments. Adjusted EPS rose 16.1% to $1.73, supported by $40.0 million in operating cash flow and an 11.9% increase in adjusted EBITDA. The company attributes its success to robust organic growth, operational efficiency, and strategic acquisitions like HomeCourt Home Care.
Addus HomeCare Announces Third Quarter 2026 Earnings Release and Conference Call
Addus HomeCare Corporation (Nasdaq: ADUS) has announced its third-quarter 2026 earnings will be released on Tuesday, November 3, 2026, after market close. The company will host a conference call on Wednesday, November 4, 2026, at 9:00 a.m. Eastern Time, featuring Chairman and CEO Dirk Allison and EVP and CFO Brian Poff. Details for accessing the live call and telephonic replay have been provided.
Addus HomeCare Q3FY26 Results: Earnings release set for November 3
Addus HomeCare Corporation will release its Q3 FY26 earnings on November 3, 2026, after market close, followed by a conference call on November 4, 2026, at 9:00 am ET. CEO Dirk Allison and CFO Brian Poff will discuss the results. The company provides home care services to approximately 62,500 patients across 24 states.
Addus HomeCare Announces Third Quarter 2026 Earnings Release and Conference Call
Addus HomeCare Corporation (Nasdaq: ADUS) will release its third-quarter 2026 earnings on Tuesday, November 3, 2026, after the market closes. The company will also host a conference call on Wednesday, November 4, 2026, at 9:00 a.m. Eastern Time, with CEO Dirk Allison and CFO Brian Poff to discuss the results. Addus HomeCare provides home care, hospice, and home health services to approximately 62,500 patients across 24 states.
Addus HomeCare Corporation (ADUS) Stock forecasts
Argus has provided a quantitative report on Addus HomeCare Corporation (ADUS), which specializes in in-home personal care services. The report indicates a current stock price of $114.33 for ADUS. Investors can access the full report for detailed insights and a price target.
Addus HomeCare stock heads into an October 8 investor meeting
Addus HomeCare (ADUS) stock is heading into a virtual investor meeting with Citizens on October 8, 2026, following its Q2 earnings report. The company reported an 8.0% increase in Q2 revenue to USD 377.41 million and adjusted EPS of USD 1.73, exceeding consensus estimates. Analysts have a "Moderate Buy" consensus with an average target price of USD 129.33, suggesting a 14.3% upside from its October 6 price of USD 113.16.
BofA cuts Addus HomeCare stock target from USD 140.00 to USD 125.00
BofA has reduced its stock target for Addus HomeCare (ADUS) from $140.00 to $125.00, downgrading it to Neutral following the company's acquisition of AccentCare's personal care division for $275.00 million. This acquisition is expected to significantly increase Addus HomeCare's annualized personal care revenue. The company reported strong second-quarter 2026 results with an 8% increase in net service revenue and a rise in net income and diluted earnings per share.
BofA cuts target for Addus HomeCare stock to USD 125.00
BofA Securities has reduced its target price for Addus HomeCare (ADUS) stock from $140.00 to $125.00, citing the revised target as still 12.34% above the Nasdaq close. Despite this cut, the company reported strong second-quarter growth with an 8% increase in revenue to $377.40 million and diluted earnings per share rising to $1.49. Addus HomeCare is also scheduled to meet virtually with Citizens on October 8, 2026.
Addus HomeCare stock crossed its 200-day average on October 2
Addus HomeCare (ADUS) stock closed above its 200-day average on October 2, trading at $111.27 after reaching an intra-day high of $113.08. The company recently announced the acquisition of AccentCare's personal care division, which is expected to significantly increase its annual revenue. Despite a "Moderate Buy" analyst consensus, some caution remains regarding organic growth and reimbursement exposure, as reflected in a recent rating downgrade by BofA Securities.
Raymond James targets Addus HomeCare stock at USD 137.00
Raymond James has set a price target of USD 137.00 for Addus HomeCare, initiating coverage with an Outperform rating. This target reflects optimism about the company's growth potential through home-based care demand and acquisitions, following an 8% increase in second-quarter revenue. However, BofA Securities offered a contrasting view, cutting its target and downgrading the stock due to concerns about slower organic growth.
Addus HomeCare Corporation (ADUS) stock price, news, quote and history
This page provides a comprehensive overview of Addus HomeCare Corporation (ADUS), including its current stock price, financial data, and company profile. As of October 2, 2026, ADUS closed at $111.27 with a slight decrease of 0.38%. The company offers personal care, hospice, and home health services, primarily catering to elderly, chronically ill, and disabled individuals.
Why home health expansions are a power play in value-based care
The article discusses how home health expansions by companies like Bayada and Addus HomeCare are strategic moves to secure value-based care contracts. These expansions are highlighted as a significant power play within the evolving landscape of healthcare.
Addus HomeCare stock gets a USD 137.00 target from Raymond James
Raymond James has initiated coverage on Addus HomeCare (ADUS) with an Outperform rating and a $137.00 price target. This comes as Addus prepares to integrate its acquisition of AccentCare's personal care business, which is expected to add $280.0 million in annualized personal-care revenue. The company recently reported Q2 revenue of $377.40 million, an 8.00 percent increase year-over-year, and will announce its next earnings on November 2, 2026.
Addus HomeCare stock initiated at Outperform by Raymond James
Raymond James initiated coverage on Addus HomeCare (NASDAQ:ADUS) with an Outperform rating and a $137 price target, citing sustained growth potential through organic expansion and acquisitions in the home-based care sector. The firm believes the stock is undervalued at current levels, with a P/E ratio of 19.75 and a PEG ratio of 0.75. Addus HomeCare recently acquired AccentCare for approximately $275 million, which is expected to add nearly 20% to revenue and improve margins.